Skip to main content

Dr. Resar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Resar's full profile

Already have an account?

  • Office

    601 North Caroline Street
    Baltimore, MD 21287
    Phone+1 410-955-3142
    Fax+1 410-614-8601

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1989 - 1992
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Pediatrics, 1986 - 1989
  • Medical College of Wisconsin
    Medical College of WisconsinClass of 1986

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1989 - 2025
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • High Mobility Group A1 Chromatin Regulators: Key Epigenetic Switches and Therapeutic Targets Required for Leukemic Transformation in JAK2 Mutant MPN
    Linda Resar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Worse Outcomes in Males with MPN Are Associated with Qualitative and Quantitative Differences in Non-Driver Mutational Burden
    Linda Resar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • High Mobility Group A1 Chromatin Regulators Function As Critical Drivers of Leukemogenesis in Preclinical Models of Relapsed, Pediatric B-Cell ALL
    Linda Resar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Press Mentions

  • Study Discover Novel Cell Signaling Pathway for Deadly Pancreatic Cancers
    Study Discover Novel Cell Signaling Pathway for Deadly Pancreatic CancersApril 25th, 2023
  • Maryland Stem Cell Research Commission Announces over $6 Million in Awards to Accelerate Cures
    Maryland Stem Cell Research Commission Announces over $6 Million in Awards to Accelerate CuresMay 9th, 2021
  • Bloodless Medicine | Hazel's Story
    Bloodless Medicine | Hazel's StoryJuly 3rd, 2019
  • Join now to see all